We’re expanding our Strategic Advisory Board with two former FDA leaders, Tala Fakhouri and Sean Khozin. Their guidance ensures Weave stays grounded in how regulators actually assess a submission, not in assumptions about it.
Press release
Two Former FDA Leaders Join Weave Bio’s Strategic Advisory Board
Related news
Press release
Weave Bio Appoints Krates Ng as Chief Technology Officer to Power Enterprise-Scale Regulatory AI
Press release
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
Press release
Weave Bio Enables Global Submissions From a Single Source of Truth
News